Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Isolated polycystic liver disease genes define effectors of polycystin-1 function
Whitney Besse, … , Vicente E. Torres, Stefan Somlo
Whitney Besse, … , Vicente E. Torres, Stefan Somlo
Published April 4, 2017
Citation Information: J Clin Invest. 2017;127(5):1772-1785. https://doi.org/10.1172/JCI90129.
View: Text | PDF | Corrigendum
Research Article Genetics Nephrology Article has an altmetric score of 61

Isolated polycystic liver disease genes define effectors of polycystin-1 function

  • Text
  • PDF
Abstract

Dominantly inherited isolated polycystic liver disease (PCLD) consists of liver cysts that are radiologically and pathologically identical to those seen in autosomal dominant polycystic kidney disease, but without clinically relevant kidney cysts. The causative genes are known for fewer than 40% of PCLD index cases. Here, we have used whole exome sequencing in a discovery cohort of 102 unrelated patients who were excluded for mutations in the 2 most common PCLD genes, PRKCSH and SEC63, to identify heterozygous loss-of-function mutations in 3 additional genes, ALG8, GANAB, and SEC61B. Similarly to PRKCSH and SEC63, these genes encode proteins that are integral to the protein biogenesis pathway in the endoplasmic reticulum. We inactivated these candidate genes in cell line models to show that loss of function of each results in defective maturation and trafficking of polycystin-1, the central determinant of cyst pathogenesis. Despite acting in a common pathway, each PCLD gene product demonstrated distinct effects on polycystin-1 biogenesis. We also found enrichment on a genome-wide basis of heterozygous mutations in the autosomal recessive polycystic kidney disease gene PKHD1, indicating that adult PKHD1 carriers can present with clinical PCLD. These findings define genetic and biochemical modulators of polycystin-1 function and provide a more complete definition of the spectrum of dominant human polycystic diseases.

Authors

Whitney Besse, Ke Dong, Jungmin Choi, Sohan Punia, Sorin V. Fedeles, Murim Choi, Anna-Rachel Gallagher, Emily B. Huang, Ashima Gulati, James Knight, Shrikant Mane, Esa Tahvanainen, Pia Tahvanainen, Simone Sanna-Cherchi, Richard P. Lifton, Terry Watnick, York P. Pei, Vicente E. Torres, Stefan Somlo

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 Total
Citations: 2 8 15 13 9 14 5 9 4 79
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (79)

Title and authors Publication Year
The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease
Bi J, Guo W, Ji P, Li S, Wang P, Li Q, Xie Y
Clinical Kidney Journal 2025
Phenotypic outcomes of PKD1 compared with non-PKD1 genetically confirmed autosomal dominant polycystic kidney disease.
Elhassan EAE, O'Donoghue D, Heneghan S, Teltsh O, Sarihan S, Osman SM, Clince M, Synnott D, Craig S, Hudson A, Doyle B, Lappin D, Sexton DJ, Casserly L, Holian J, Magee C, Denton M, Sweeney C, Awan A, McCann E, Cavalleri GL, Benson KA, Conlon PJ
Journal of nephrology 2025
Quantifying variant contributions in cystic kidney disease using national-scale whole genome sequencing
Omid Sadeghi-Alavijeh, Melanie Chan, Gabriel Doctor, Catalin Voinescu, Alexander Stuckey, Athanasios Kousathanas, Alexander Ho, Genomics Consortium, Horia Stanescu, Detlef Bockenhauer, Richard Sandford, Adam Levine, Daniel Gale
Journal of Clinical Investigation 2024
Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease
Mahboobipour AA, Ala M, Safdari Lord J, Yaghoobi A
Orphanet Journal of Rare Diseases 2024
Comparative analysis of SEC61A1 mutant R236C in two patient-derived cellular platforms
Weiand M, Sandfort V, Nadzemova O, Schierwagen R, Trebicka J, Schlevogt B, Kabar I, Schmidt H, Zibert A
Scientific Reports 2024
How Does ADPKD Severity Differ Between Family Members?
Yeung KC, Fryml E, Lanktree MB
Kidney International Reports 2024
Pathogenic relationship between phenotypes of ARPKD and novel compound heterozygous mutations of PKHD1
Zhang X, Wu J, Zhou J, Liang J, Han Y, Qi Y, Zhu T, Yuan D, Zhu Z, Zhai J
Frontiers in Genetics 2024
Single-Base Substitution Causing Dual-Exon Skipping Event in PKD2 Gene: Unusual Molecular Finding from Exome Sequencing in a Patient with Autosomal Dominant Polycystic Kidney Disease
De Paolis E, Raspaglio G, Ciferri N, Zangrilli I, Ricciardi Tenore C, Urbani A, Ferraro PM, Minucci A, Concolino P
Journal of Clinical Medicine 2024
Exquisite sensitivity of Polycystin-1 to H2O2 concentration in the endoplasmic reticulum
Speranza E, Sorrentino I, Boletta A, Sitia R
Redox Biology 2024
Liver manifestations in autosomal dominant polycystic kidney disease (ADPKD) and their impact on quality of life
Arjune S, Todorova P, Bartram MP, Grundmann F, Müller RU
Clinical Kidney Journal 2024
Predominant Liver Cystic Disease in a New Heterozygotic PKHD1 Variant: A Case Report
Van Buren JD, Neuman JT, Sidlow R
2023
The ER Protein Translocation Channel Subunit Sbh1 Controls Virulence of Cryptococcus neoformans
Santiago-Tirado FH, Hurtaux T, Geddes-McAlister J, Nguyen D, Helms V, Doering TL, Römisch K
mBio 2023
KidneyNetwork: using kidney-derived gene expression data to predict and prioritize novel genes involved in kidney disease.
Boulogne F, Claus LR, Wiersma H, Oelen R, Schukking F, de Klein N, Li S, Westra HJ, van der Zwaag B, van Reekum F, Sierks D, Schönauer R, Li Z, Bijlsma EK, Bos WJW, Halbritter J, Knoers NVAM, Besse W, Deelen P, Franke L, van Eerde AM
European journal of human genetics : EJHG 2023
The C-terminal tail of polycystin-1 suppresses cystic disease in a mitochondrial enzyme-dependent fashion.
Onuchic L, Padovano V, Schena G, Rajendran V, Dong K, Shi X, Pandya R, Rai V, Gresko NP, Ahmed O, Lam TT, Wang W, Shen H, Somlo S, Caplan MJ
Nature Communications 2023
Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress
Hu C, Xin Z, Sun X, Hu Y, Zhang C, Yan R, Wang Y, Lu M, Huang J, Du X, Xing B, Liu X
Journal of experimental & clinical cancer research : CR 2023
Identified eleven exon variants in PKD1 and PKD2 genes that altered RNA splicing by minigene assay
Liu X, Shi X, Xin Q, Liu Z, Pan F, Qiao D, Chen M, Zhang Y, Guo W, Li C, Zhang Y, Shao L, Zhang R
BMC Genomics 2023
Hypomorphic PKD1 Alleles Impact Disease Variability in Autosomal Dominant Polycystic Kidney Disease.
Gulati A, Dahl NK, Hartung EA, Clark SL, Moudgil A, Goodwin J, Somlo S
2023
NOTCH signalling – a core regulator of bile duct disease?
Martinez Lyons A, Boulter L
Disease models & mechanisms 2023
Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum
Boerrigter MM, te Morsche RH, Venselaar H, Pastoors N, Geerts AM, Hoorens A, Drenth JP
Genes & development 2023
Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice
Ghosh Roy S, Li Z, Guo Z, Tran Long K, Rehrl S, Tian X, Dong K, Besse W
Journal of the American Society of Nephrology : JASN 2023
Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
Boerrigter MM, Duijzer R, te Morsche RH, Drenth JP
Genes & development 2023
Quantitative Mass Spectrometry Characterizes Client Spectra of Components for Targeting of Membrane Proteins to and Their Insertion into the Membrane of the Human ER
Jung M, Zimmermann R
International journal of molecular sciences 2023
A TGFβ-ECM-Integrin signalling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease
Waddell SH, Yao Y, Olaizola P, Walker A, Jarman EJ, Gournopanos K, Gradinaru A, Christodoulou E, Gautier P, Boerrigter MM, Cadamuro M, Fabris L, Drenth JP, Kendall TJ, Banales JM, Khamseh A, Mill P, Boulter L
Science Translational Medicine 2023
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease
Claus LR, Chen C, Stallworth J, Turner JL, Slaats GG, Hawks AL, Mabillard H, Senum SR, Srikanth S, Flanagan-Steet H, Louie RJ, Silver J, Lerner-Ellis J, Morel C, Mighton C, Sleutels F, van Slegtenhorst M, van Ham T, Brooks AS, Dorresteijn EM, Barakat TS, Dahan K, Demoulin N, Goffin EJ, Olinger E, Larsen M, Hertz JM, Lilien MR, Obeidová L, Seeman T, Stone HK, Kerecuk L, Gurgu M, Yengej FA, Ammerlaan CM, Rookmaaker MB, Hanna C, Rogers RC, Duran K, Peters E, Sayer JA, van Haaften G, Harris PC, Ling K, Mason JM, van Eerde AM, Steet R
Kidney International 2023
Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes
Yang H, Sieben CJ, Schauer RS, Harris PC
2023
Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype
S Senum, Y Li, K Benson, G Joli, E Olinger, S Lavu, C Madsen, A Gregory, R Neatu, T Kline, M Audrézet, P Outeda, C Nau, E Meijer, H Ali, T Steinman, M Mrug, P Phelan, T Watnick, D Peters, A Ong, P Conlon, R Perrone, E Gall, M Hogan, V Torres, J Sayer, P Harris
The American Journal of Human Genetics 2022
Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
P Olaizola, P Rodrigues, F Caballero-Camino, L Izquierdo-Sanchez, P Aspichueta, L Bujanda, N Larusso, J Drenth, M Perugorria, J Banales
Nature Reviews Gastroenterology & Hepatology 2022
Polycystic Liver Disease: Advances in Understanding and Treatment
T Masyuk, A Masyuk, N LaRusso
Annual review of pathology 2022
Imaging of fibropolycystic liver disease
K Sharbidre, M Zahid, S Venkatesh, C Bhati, N Lalwani
Abdominal Radiology 2022
GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
De Masi R, Orlando S
International journal of molecular sciences 2022
Signal Peptide Features Determining the Substrate Specificities of Targeting and Translocation Components in Human ER Protein Import.
Lang S, Nguyen D, Bhadra P, Jung M, Helms V, Zimmermann R
Frontiers in physiology 2022
Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment
Norcia LF, Watanabe EM, Hamamoto Filho PT, Hasimoto CN, Pelafsky L, de Oliveira WK, Sassaki LY
Hepatic medicine : evidence and research 2022
A single-center analysis of genotype–phenotype characteristics of Chinese patients with autosomal dominant polycystic kidney disease by targeted exome sequencing
Yan Z, Wang Y, Deng W, Zhou Y, Hu Y, Qi K, Liu D, Xia R, Liu R, Zeng W, Zhang W, Xu J, Xiong F, Miao Y
Frontiers in Genetics 2022
A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology
Aron AW, Dahl NK, Besse W
2022
Modelling polycystic liver disease progression using age-adjusted liver volumes and targeted mutational analysis
Sierks D, Schönauer R, Friedrich A, Hantmann E, de Fallois J, Linder N, Fischer J, Herber A, Bergmann C, Berg T, Halbritter J
2022
The GPCR properties of polycystin-1- A new paradigm
Maser RL, Calvet JP, Parnell SC
Frontiers in Molecular Biosciences 2022
Signal sequences encode information for protein folding in the endoplasmic reticulum.
Sun S, Li X, Mariappan M
The Journal of Cell Biology 2022
Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease.
Apple B, Sartori G, Moore B, Chintam K, Singh G, Anand PM, Strande NT, Mirshahi T, Triffo W, Chang AR
Kidney International 2022
Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease
A Cordido, M Vizoso-Gonzalez, MA Garcia-Gonzalez
International journal of molecular sciences 2021
Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings
MP Wilson, A Garanto, FP e Vairo, BG Ng, WK Ranatunga, M Ventouratou, M Baerenfaenger, K Huijben, C Thiel, A Ashikov, L Keldermans, E Souche, S Vuillaumier-Barrot, T Dupré, H Michelakakis, A Fiumara, J Pitt, SM White, SC Lim, L Gallacher, H Peters, D Rymen, P Witters, A Ribes, B Morales-Romero, A Rodríguez-Palmero, D Ballhausen, P de Lonlay, R Barone, MC Janssen, J Jaeken, HH Freeze, G Matthijs, E Morava, DJ Lefeber
The American Journal of Human Genetics 2021
Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
PY LeeLaw, P Olaizola, FJ CaballeroCamino, L IzquierdoSanchez, PM Rodrigues, MJ Perugorria, M Azkargorta, F Elortza, ML MartinezChantar, P Aspichueta, M Marzioni, L Bujanda, JP Drenth, JM Banales
United European gastroenterology journal 2021
Complexity and Specificity of Sec61-Channelopathies: Human Diseases Affecting Gating of the Sec61 Complex
M Sicking, S Lang, F Bochen, A Roos, JP Drenth, M Zakaria, R Zimmermann, M Linxweiler
Cells 2021
Polycystic liver disease with lethal abdominal wall rupture: a case report
D Akuzawa, Y Uchida, T Ishimura, H Kakita, T Endo, N Matsuzaki, H Terajima, T Tsukamoto
Journal of medical case reports 2021
Challenging Disease Ontology by Instances of Atypical PKHD1 and PKD1 Genetics
J de Fallois, R Schönauer, J Münch, M Nagel, B Popp, J Halbritter
Frontiers in Genetics 2021
Association of a novel PKHD1 mutation in a family with autosomal dominant polycystic liver disease
J Wang, H Yang, R Guo, X Sang, Y Mao
Annals of translational medicine 2021
A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer
L Wang
International journal of general medicine 2021
The Molecular Biodiversity of Protein Targeting and Protein Transport Related to the Endoplasmic Reticulum
A Tirincsi, M Sicking, D Hadzibeganovic, S Haßdenteufel, S Lang
International journal of molecular sciences 2021
Adhesion GPCRs as a paradigm for understanding polycystin-1 G protein regulation
RL Maser, JP Calvet
Cellular Signalling 2020
Regulation of polycystin expression, maturation and trafficking
J Hu, PC Harris
Cellular Signalling 2020
Novel GANAB variants associated with polycystic liver disease
LF van de Laarschot, RH te Morsche, A Hoischen, H Venselaar, HM Roelofs, WR Cnossen, JM Banales, R Roepman, JP Drenth
Orphanet Journal of Rare Diseases 2020
Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families
V Mantovani, S Bin, C Graziano, I Capelli, R Minardi, V Aiello, E Ambrosini, CP Cristalli, A Mattiaccio, M Pariali, SD Fanti, F Faletra, E Grosso, R Cantone, E Mancini, F Mencarelli, A Pasini, A Wischmeijer, N Sciascia, M Seri, GL Manna
Frontiers in Genetics 2020
Matching clinical and genetic diagnoses in autosomal dominant polycystic kidney disease reveals novel phenocopies and potential candidate genes
R Schönauer, S Baatz, M Nemitz-Kliemchen, V Frank, F Petzold, S Sewerin, B Popp, J Münch, S Neuber, C Bergmann, J Halbritter
Genetics in Medicine 2020
Proteostasis disturbances and endoplasmic reticulum stress contribute to polycystic liver disease: New therapeutic targets
A SantosLaso, L IzquierdoSanchez, PM Rodrigues, BQ Huang, M Azkargorta, A Lapitz, P MunozGarrido, A Arbelaiz, FJ Caballero-Camino, MG FernándezBarrena, R JimenezAgüero, J Argemi, T Aragon, F Elortza, M Marzioni, JP Drenth, NF LaRusso, L Bujanda, MJ Perugorria, JM Banales, E Andersson
Liver International 2020
Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management
ZY Zhang, ZM Wang, Y Huang
World journal of hepatology 2020
Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county
T Suwabe, AM Chamberlain, JM Killian, BF King, AV Gregory, CD Madsen, X Wang, TL Kline, FT Chebib, MC Hogan, PS Kamath, PC Harris, VE Torres
2020
Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
J Griffiths, MT Mills, AC Ong
BMJ Open 2020
Type IV choledochal cyst with polycystic kidney disease: a case report
Y He, Z Yu, W Chen
BMC Gastroenterology 2020
Use of patient derived urine renal epithelial cells to confirm pathogenicity of PKHD1 alleles
E Molinari, S Srivastava, RM Dewhurst, JA Sayer
BMC Nephrology 2020
Exploring the Spectrum of Kidney Ciliopathies
M Santoni, F Piva, A Cimadamore, M Giulietti, N Battelli, R Montironi, L Cosmai, C Porta
Diagnostics 2020
Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial
MC Hogan, JA Chamberlin, LE Vaughan, AL Waits, C Banks, K Leistikow, T Oftsie, C Madsen, M Edwards, J Glockner, WK Kremers, PC Harris, NF LaRusso, VE Torres, TV Masyuk
Clinical journal of the American Society of Nephrology : CJASN 2020
Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease
Huynh VT, Audrézet MP, Sayer JA, Ong AC, Lefevre S, Le Brun V, Després A, Senum SR, Chebib FT, Barroso-Gil M, Patel C, Mallett AJ, Goel H, Mallawaarachchi AC, Van Eerde AM, Ponlot E, Kribs M, Le Meur Y, Harris PC, Gall EC
Kidney International 2020
Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases
L Fabris, R Fiorotto, C Spirli, M Cadamuro, V Mariotti, MJ Perugorria, JM Banales, M Strazzabosco
Nature Reviews Gastroenterology & Hepatology 2019
Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models
RJ Olson, K Hopp, H Wells, JM Smith, J Furtado, MM Constans, DL Escobar, AM Geurts, VE Torres, PC Harris
Journal of the American Society of Nephrology : JASN 2019
Heterozygous Pkhd1C642* mice develop cystic liver disease and proximal tubule ectasia that mimics radiographic signs of medullary sponge kidney
D Shan, G Rezonzew, S Mullen, R Roye, J Zhou, P Chumley, DZ Revell, A Challa, H Kim, ME Lockhart, TR Schoeb, MJ Croyle, RA Kesterson, BK Yoder, LM Guay-Woodford, M Mrug
American journal of physiology. Renal physiology 2019
Contributions of Rare Gene Variants to Familial and Sporadic FSGS
M Wang, J Chun, G Genovese, AU Knob, A Benjamin, MS Wilkins, DJ Friedman, GB Appel, RP Lifton, S Mane, MR Pollak
Journal of the American Society of Nephrology : JASN 2019
Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County
T Suwabe, S Shukoor, AM Chamberlain, JM Killian, BF King, M Edwards, SR Senum, CD Madsen, FT Chebib, MC Hogan, EC Gall, PC Harris, VE Torres
Clinical journal of the American Society of Nephrology : CJASN 2019
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease
EC Gall, RJ Olson, W Besse, CM Heyer, VG Gainullin, JM Smith, MP Audrézet, K Hopp, B Porath, B Shi, S Baheti, SR Senum, J Arroyo, CD Madsen, C Férec, D Joly, F Jouret, O Fikri-Benbrahim, C Charasse, JM Coulibaly, AS Yu, K Khalili, Y Pei, S Somlo, YL Meur, VE Torres, PC Harris
The American Journal of Human Genetics 2018
Polycystin-1, the product of the polycystic kidney disease gene PKD1, is post-translationally modified by palmitoylation
K Roy, EP Marin
Molecular Biology Reports 2018
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing
MB Lanktree, A Haghighi, E Guiard, IA Iliuta, X Song, PC Harris, AD Paterson, Y Pei
Journal of the American Society of Nephrology : JASN 2018
The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations
EC Gall, FT Chebib, CD Madsen, SR Senum, CM Heyer, BC Lanpher, MC Patterson, RC Albright, AS Yu, VE Torres, PC Harris, KZ Abebe, KT Bae, RW Schrier, AB Chapman, RD Perrone, WE Braun, TI Steinman
American journal of kidney diseases : the official journal of the National Kidney Foundation 2018
PUF60-activated exons uncover altered 3′ splice-site selection by germline missense mutations in a single RRM
J Královičová, I Ševčíková, E Stejskalová, M Obuća, M Hiller, D Staněk, I Vořechovský
Nucleic Acids Research 2018
A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family
W Besse, J Choi, D Ahram, S Mane, S Sanna-Cherchi, V Torres, S Somlo
Human Mutation 2018
Polycystic liver disease: The interplay of genes causative for hepatic and renal cystogenesis: Hepatology Elsewhere
TV Masyuk, AI Masyuk, NF LaRusso
Hepatology 2018
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
FT Chebib, RD Perrone, AB Chapman, NK Dahl, PC Harris, M Mrug, RA Mustafa, A Rastogi, T Watnick, AS Yu, VE Torres
Journal of the American Society of Nephrology : JASN 2018
Mutations in chromatin modifier and Ephrin signaling genes in Vein of Galen malformation
Duran D, Zeng X, Jin SC, Choi J, Nelson-Williams C, Yatsula B, Gaillard J, Furey CG, Lu Q, Timberlake AT, Dong W, Sorscher MA, Loring E, Klein J, Allocco A, Hunt A, Conine S, Karimy JK, Youngblood MW, Zhang J, DiLuna ML, Matouk CC, Mane S, Tikhonova IR, Castaldi C, López-Giráldez F, Knight J, Haider S, Soban M, Alper SL, Komiyama M, Ducruet AF, Zabramski JM, Dardik A, Walcott BP, Stapleton CJ, Aagaard-Kienitz B, Rodesch G, Jackson E, Smith ER, Orbach DB, Berenstein A, Bilguvar K, Vikkula M, Gunel M, Lifton RP, Kahle KT
Neuron 2018
New treatment paradigms for ADPKD: moving towards precision medicine
MB Lanktree, AB Chapman
Nature Reviews Nephrology 2017
Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases
EC Gall, VE Torres, PC Harris
Journal of the American Society of Nephrology : JASN 2017
Genetics: Novel causative genes for polycystic liver disease
MJ Perugorria, JM Banales
Nature Reviews Gastroenterology & Hepatology 2017
An Update on Sec61 Channel Functions, Mechanisms, and Related Diseases
S Lang, S Pfeffer, PH Lee, A Cavalié, V Helms, F Förster, R Zimmermann
Frontiers in physiology 2017

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 7 news outlets
Blogged by 1
Posted by 4 X users
Highlighted by 1 platforms
115 readers on Mendeley
See more details